509 related articles for article (PubMed ID: 1453767)
21. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
22. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
Sun GL
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
[TBL] [Abstract][Full Text] [Related]
24. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Eardley AM; Heller G; Warrell RP
Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
[TBL] [Abstract][Full Text] [Related]
25. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival.
Degos L
Leukemia; 1994; 8 Suppl 2():S6-8. PubMed ID: 7815840
[TBL] [Abstract][Full Text] [Related]
26. [Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment].
Ikeda Y; Yoshinaga K; Iki S; Ohbayashi Y; Urabe A
Rinsho Ketsueki; 1994 Feb; 35(2):183-7. PubMed ID: 8139118
[TBL] [Abstract][Full Text] [Related]
27. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
[TBL] [Abstract][Full Text] [Related]
28. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura U; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Tsubaki K; Saito K; Kuriyama K; Oh H; Kitano K; Miyawaki S; Takeyama U; Yamada O; Nishikawa K; Takahashi M; Matsuda S; Ohtake H; Ohno R
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370
[TBL] [Abstract][Full Text] [Related]
29. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
30. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
31. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.
Fenaux P; Chastang C; Degos L
Leukemia; 1994; 8 Suppl 2():S42-7. PubMed ID: 7815836
[TBL] [Abstract][Full Text] [Related]
32. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
[TBL] [Abstract][Full Text] [Related]
33. [Acute promyelocytic leukemia associated with hemophagocytic syndrome].
Jinta M; Arai A; Yamamoto K; Sakashita C; Fukuda T; Miu T; Koyama T; Murakami N; Miura O
Rinsho Ketsueki; 2007 Apr; 48(4):310-4. PubMed ID: 17515122
[TBL] [Abstract][Full Text] [Related]
34. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
35. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
Ohno R; Naoe T; Fukutani H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1016-21. PubMed ID: 8390226
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
37. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
[TBL] [Abstract][Full Text] [Related]
38. [Experience in administration low dose all-trans retinoic acid for a child with acute promyelocytic leukemia].
Hata M; Nakayama T; Hattori T; Okano S; Ito T; Abe T; Kamakura M; Iinuma H; Okinaga K; Yasuda K
Rinsho Ketsueki; 1996 Feb; 37(2):129-33. PubMed ID: 8852030
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
40. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
